
Global RNA-Based Therapies Market to Reach US$213.54B by 2033, Driven by Genetic & Rare Disease Innovations
Antisense Oligonucleotides lead with 25.5% share; North America dominates while Asia-Pacific emerges as a high-growth region. AUSTIN, TX, UNITED STATES, September 29, 2025 /EINPresswire.com/ -- The global RNA-based therapies market Size is …